TIDMCTEA
RNS Number : 6275I
Catenae Innovation PLC
15 December 2020
15 December 2020
Catenae Innovation PLC
("Catenae", the "Company" or the "Group")
Business Update
Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of
digital media and technology, announces that, further to the
announcement made by the Company on 16 October 2020, it has renamed
its 50/50 Joint Venture Company to Synovate Global Limited
("Synovate") and Synovate has received its first orders.
Synovate is a joint venture between Catenae and BHA-Medical
("BHA") in which Catenae licenses its technology platforms and BHA
provides its Covid-19 CE-certified and scientifically validated by
the UK Government Near-Patient Healgen Antigen test and its
Covid-19 CE-certified Near-Patient Antai Triple-Antibody test.
Through Synovate, BHA has provided badminton's national
governing body - Badminton England with its Near-Patient Healgen
Antigen test kits, and Catenae has supplied its GDPR-compliant data
management platform, for the Badminton Europe Qualification Group 1
matches that took place in Milton Keynes between 9 - 12 December
2020.
Synovate's partner, ECG Training, conducted the tests on the
participating teams from England, Sweden, Estonia and Hungary, and
all of the test results were securely logged and managed using
Catenae's platform through Synovate. The data was then submitted to
Public Health England (PHE), for input into the NHS's 'Test and
Trace' platform, and the players received their test results via
SMS text message and email.
Through Synovate, BHA's Covid-19 test kits and Catenae's data
management platform have also been supplied to Stone Bailey, a
security, safety and medical solutions organisation, for use at
"Lapland UK", a Christmas destination event near Ascot in
Surrey.
Under the terms of the agreement with Stone Bailey, BHA provide
the CE-certified Near-Patient Antai Triple-Antibody test kits for
the venue staff, and have ensured that Stone Bailey received the
training required to carry out the ongoing testing procedure. All
test results are securely recorded on Catenae's data management
portal through Synovate and input into Public Health England.
Albeit neither the Badminton England nor the Stone Bailey
agreements will generate significant revenues for the Company, it
provides a commercial endorsement for Synovate's offering.
The Synovate website can be viewed at this link:
www.synovateglobal.com .
Guy Meyer, Chief Executive Officer of Catenae, said: "We are
delighted to officially launch Synovate and to be able to provide
commercial organisations with a comprehensive offering that they
can use to test and securely manage Covid-19 cases within their
corporations. Importantly, Synovate ensures that results from both
Antigen and Antibody test are fed into PHE, where, in turn, they
are inputted into the NHS's 'Test and Trace' platform. Our platform
is able to accept tests results from a range of differing testing
procedures and is also able to accept an individual's vaccination
information.
"Utilising the sales expertise of our newly appointed Chief
Commercial Officer, Nick Delacamp, we are experiencing increased
interest for Synovate's services from organisations across a range
of industries, and we look forward to keeping the market updated on
further progress in due course."
Matt Stone, Managing Director of Stone Bailey, commented: "We
are proud to be leading the way in managing the safety of our teams
and visitors to Lapland UK. The testing system has made it quick
and easy for us to conduct the tests and inform both the end-users
and Public Health England of the outcomes."
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014. The person who arranged for
release of this announcement on behalf of the Company was Guy
Meyer, Chief Executive Officer of the Company and the Directors of
the Company accept responsibility for the content of this
announcement.
For further information please contact:
+44 (0)191 580
Catenae Innovation PLC 8545
Guy Meyer, Chief Executive Officer
Cairn Financial Advisers LLP (Nominated Adviser) +44(0)20 7213 0880
Liam Murray / Jo Turner
+44 (0)20 3463
Brandon Hill Capital Limited, Broker 5000
Andy Gutmann
+44 (0)20 3004
Yellow Jersey PR (PR & IR) 9512
Sarah Hollins / Annabel Atkins / Matthew McHale
Notes to Editors:
About Catenae Innovation PLC
Catenae Innovation is an AIM quoted provider of digital media
and technology services. Catenae use the power of blockchain to
deliver solutions where its people-centric technology enables trust
and certainty allowing organisations to gain better control over
their operations, manage staff and safely welcome customers.
www.catenaeinnovation.com
About Synovate Global
Synovate Global is a joint venture between BHA-Medical and
Catenae Innovation PLC. BHA -Medical provides the most advanced
technologies in the field of medicine. It combines this with
clinical expertise and excellence to deliver an enriched quality of
service for its customers across the globe.
Catenae is at the forefront of digital transformation globally.
It provides a range of solutions which help organisations to better
manage and control their operations through safe, secure Data
Management Platforms, Digital Passport Apps and Dynamic Data
Intelligence Dashboards.
Synovate Global's purpose is to enable businesses and
organisations to operate with confidence, safety and optimal
efficiency. It helps to mitigate risk and proactively manage the
population's health status through cutting edge medical products,
supported by clinical and occupational health services and
underpinned by undisputed blockchain technology.
www.synovateglobal.com
About Badminton England
Badminton England is the national governing body for the sport
of badminton in England. It aims to govern, encourage and develop
the sport throughout England.
https://www.badmintonengland.co.uk/
About Stone Bailey
Stone Bailey is an organisation that provides a full security
service and advise on safety, medical and risk management
practices. Using its specialist knowledge and expertise in
vigilance and diligence, it establishes a clear sense of direction
to ensure it offers an exceptional service from concept to
completion.
https://stone-bailey.com/
Forward-Looking Statements
Certain statements made in this announcement are forward-looking
statements. These forward-looking statements are not historical
facts but rather are based on the Company's current expectations,
estimates, and projections about its industry; its beliefs; and
assumptions. Words such as 'anticipates,' 'expects,' 'intends,'
'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions
are intended to identify forward-looking statements. These
statements are not guarantees of future performance and are subject
to known and unknown risks, uncertainties, and other factors, some
of which are beyond the Company's control, are difficult to
predict, and could cause actual results to differ materially from
those expressed or forecasted in the forward-looking
statements.
The Company cautions security holders and prospective security
holders not to place undue reliance on these forward-looking
statements, which reflect the view of the Company only as of the
date of this announcement. The forward-looking statements made in
this announcement relate only to events as of the date on which the
statements are made. The Company will not undertake any obligation
to release publicly any revisions or updates to these
forward-looking statements to reflect events, circumstances, or
unanticipated events occurring after the date of this announcement
except as required by law or by any appropriate regulatory
authority.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDFFUEELESSESE
(END) Dow Jones Newswires
December 15, 2020 02:00 ET (07:00 GMT)
Catenae Innovation (LSE:CTEA)
Historical Stock Chart
From Apr 2024 to May 2024
Catenae Innovation (LSE:CTEA)
Historical Stock Chart
From May 2023 to May 2024